History | Topotecan for the treatment of recurrent and stage IVB cervical cancer | Guidance | NICE

History

A list of downloadable documents created during development.

Background information

TA183 Cervical cancer (recurrent) - topotecan: review decision - December 2012 information
Appendix A: decision paper presented to the Institute's Guidance Executive ^{PDF 57 KB} 03 December 2012
Cervical cancer (recurrent) - topotecan: review proposal - September 2012 information
Appendix A: provisional matrix of stakeholders ^{PDF 64 KB} 10 September 2012
Appendix B: proposal paper presented to the Institute's Guidance Executive ^{PDF 343 KB} 10 September 2012

Cervical cancer (recurrent) - topotecan: final appraisal determination

Cervical cancer (recurrent) - topotecan: final appraisal determination information
Cervical cancer (recurrent) - topotecan: final appraisal determination ^{PDF 141 KB} 10 September 2009
Response to consultee and commentator comments on the appraisal consultation document ^{PDF 110 KB} 10 September 2009
Consultee and commentator comments on the ACD
Department of Health ^{PDF 7.9 KB} 10 September 2009
Royal College of Nursing ^{PDF 21 KB} 10 September 2009
GlaxoSmithKline ^{PDF 278 KB} 10 September 2009

Cervical cancer (recurrent) - topotecan: appraisal consultation

Cervical cancer (recurrent) - topotecan: appraisal consultation
Cervical cancer (recurrent) - topotecan: appraisal consultations document information
Cervical cancer (recurrent) - topotecan: evaluation report
Pre-meeting briefing ^{PDF 186 KB} 17 June 2009
Cervical cancer (recurrent) - topotecan: evidence review group report ^{PDF 875 KB} 17 June 2009
NICE clarification letter ^{PDF 474 KB} 17 June 2009
Royal College of Nursing ^{PDF 31 KB} 17 June 2009
Manufacturer submissions
Manufacturer response to clarification letter ^{PDF 395 KB} 17 June 2009
GlaxoSmithKline ^{PDF 1.21 MB} 17 June 2009
Expert written personal statements
Oakley ^{PDF 47 KB} 17 June 2009
Pendleton ^{PDF 34 KB} 17 June 2009
Symonds ^{PDF 67 KB} 17 June 2009
Hirschowitz ^{PDF 35 KB} 17 June 2009

Cervical cancer (recurrent) - topotecan: table of comments on draft scope

Cervical cancer (recurrent) - topotecan: table of comments on draft scope ^{PDF 80 KB} 09 December 2008

Cervical cancer (recurrent) - topotecan: table of comments on draft matrix

Cervical cancer (recurrent) - topotecan: table of comments on draft matrix ^{PDF 19 KB} 09 December 2008

Cervical cancer (recurrent) - topotecan: matrix

Cervical cancer (recurrent) - topotecan: matrix ^{PDF 32 KB} 25 August 2009

Cervical cancer (recurrent) - topotecan: scope

Cervical cancer (recurrent) - topotecan: scope ^{PDF 27 KB} 04 December 2008